All participants must register to attend Innovative Approaches to Pediatric Drug Development and Pediatric Medical Countermeasures: A Role for Physiologically-Based PK?, scheduled for Monday, May 5, 2014.
Thank you for your interest in Innovative Approaches to Pediatric Drug Development and Pediatric Medical Countermeasures: A Role for Physiologically-Based PK?, a conference sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and the Food and Drug Administration (FDA), and a collaboration between M-CERSI and the American College of Clinical Pharmacology (ACCP).
Registration Fees:
Cost to attend this event is determined by the participant's status:
- Faculty, Staff, and Students from the University of Maryland Baltimore and College Park Campuses: No Cost
- M-CERSI Industrial Consortia Members: No Cost
- Federal Government Employees: No Cost
- Other Participants: $50.00
Remote Access:
Remote access is available for this event free of charge. On the day of the conference, please:
- Visit https://collaboration.fda.gov/cersiconferences/
- Enter as a "Guest"
- Type your full name and organization into space provided to enter the room
Audio for this event will play through your computer speakers. If you have never attended an Adobe Connect event before, please test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm.
How to Register:
Registration for this event is now closed.